DUAL INHIBITION OF THE TWO SOURCES OF CHOLESTEROL. THE MODERN METHODOLOGY OF REDUCING CARDIOVASCULAR RISC
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 2
Abstract
This study evaluated the efficacy and safety of Ezetimibe co-administered with Simvastatine therapy in 104 hypercholesterolemic patients with coronary heart disease (CHD) or diabetes who had not achieved their low-density lipoprotein cholesterol (LDL-C) goal <100mg/dl while on a stable dose of Simvastatine 20mg/day. Significantly more patients achieved an LDL-C goal <100mg/dl with Ezetimibe than Placebo (51% vs. 35%). Compared to Placebo, co-administration of Ezetimibe with Simvastatine led to significantly greater reductions in LDL-C, total cholesterol, triglycerides, non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B; HDL-C was as well increased. Co-administration of Ezetimibe and Simvastatine was well tolerated, with an overall safety profile similar to Simvastatine alone.
Authors and Affiliations
Gabriela Dale, M. I. Popescu, Loredana Popa, A. R. Popa, R. Fritsch
Keywords
Related Articles
- EP ID EP155379
- DOI -
- Views 103
- Downloads 0
THERAPY WITH GLP-1 AGONISTS AND DIPEPTIDYL-PEPTIDASE IV INHIBITORS IN TYPE 2 DIABETES MELLITUS
Since type 2 diabetes is increasing and most patients do not reach their therapeutic goals, novel treatment options are needed. The novel therapeutic options for type 2 diabetes mellitus (Type 2 DM); respectively those b...
NOCTURNAL HYPERTENSION AND SPECIAL - PERIOD HYPERTENSION IN TYPE 1 DIABETES MELLITUS
Background: One of the unique aspects of continuous ambulatory arterial-tension monitoring is the ability of recording the diurnal variations. The patients suffering from Type 1 Diabetes Mellitus (T1DM) may present...
CORRELATIONS BETWEEN PRO-INFLAMMATORY MARKERS AND GLYCATED HEMOGLOBIN IN TYPE 2 DIABETES PATIENTS
Background and Aim. Markers of inflammation are predictive of diabetic macrovascular complications. In type 2 diabetes, inflammation might be responsible for enhancing insulin resistance and may contribute to the reducti...
Therapeutical Options For Optimizing The Glycemic Profile In A Patient With T2DM
Incretin-based therapies address some of the mechanisms of T2DM by improving β-cell function, inhibiting glucagon secretion, stimulating insulin secretion, reducing appetite and promoting weight loss. We present the case...
VALIDITY AND REPRODUCTIBILITY OF A FOOD FREQUENCY QUESTIONNAIRE DESIGNED TO CHARACTERIZE THE DIET OF WOMEN OF CHILDBEARING AGE
Objectives: To test the validity and reproducibility of a food frequency questionnaire (FFQ) administered by interview, consisting of 127 items, developed to characterize the food intake of women of fertile age, in compa...